Skip to content

Research at St Andrews

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

Research output: Contribution to journalArticlepeer-review

Author(s)

Marcos I Restrepo, Bettina L Babu, Luis F Reyes, James D Chalmers, Nilam J Soni, Oriol Sibila, Paola Faverio, Catia Cilloniz, William Rodriguez-Cintron, Stefano Aliberti, GLIMP

School/Research organisations

Abstract

Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic antibiotic resistance to the most frequently used antibiotics in patients with community-acquired pneumonia (CAP). Data about the global burden and risk factors associated with P. aeruginosa-CAP are limited. We assessed the multinational burden and specific risk factors associated with P. aeruginosa-CAP.

We enrolled 3,193 patients in 54 countries with confirmed diagnosis of CAP that underwent microbiological testing at admission. Prevalence was calculated according to the identification of P. aeruginosa. Logistic regression analysis was used to identify risk factors for antibiotic-susceptible and antibiotic-resistant P. aeruginosa-CAP.


The prevalence of P. aeruginosa and antibiotic-resistant P. aeruginosa-CAP was 4.2% and 2.0%, respectively. The rate of P. aeruginosa CAP in patients with prior infection/colonisation due to P. aeruginosa and at least one of the three independently associated chronic lung diseases [i.e., tracheostomy, bronchiectasis and/or very severe COPD]) was 67%. In contrast, the rate of P. aeruginosa CAP was 2% in patients without prior P. aeruginosa infection/colonisation and none of the selected chronic lung diseases.

The multinational prevalence of P. aeruginosa-CAP is low. The risk factors identified in this study may guide healthcare professionals in deciding empirical antibiotic coverage for CAP patients.

Close

Details

Original languageEnglish
Article number1701190
JournalEuropean Respiratory Journal
Volume52
Issue number2
DOIs
Publication statusPublished - 9 Aug 2018

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

    GLIMP investigators, Villafuerte, D., Aliberti, S., Soni, N. J., Faverio, P., Marcos, P. J., Wunderink, R. G., Rodriguez, A., Sibila, O., Sanz, F., Martin-Loeches, I., Menzella, F., Reyes, L. F., Jankovic, M., Spielmanns, M. & Restrepo, M. I., May 2020, In: Respirology. 25, 5, p. 543-551 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

    GLIMP investigators, 24 Apr 2019, In: Clinical Infectious Diseases. 68, 9, p. 1482-1493 12 p.

    Research output: Contribution to journalArticlepeer-review

  3. An international perspective on hospitalized patients with viral community-acquired pneumonia

    Radovanovic, D., Sotgiu, G., Jankovic, M., Mahesh, P. A., Marcos, P. J., Abdalla, M. I., Di Pasquale, M. F., Gramegna, A., Terraneo, S., Blasi, F., Santus, P., Aliberti, S., Reyes, L. F., Restrepo, M. I. & GLIMP Study Group, Feb 2019, In: European Journal of Internal Medicine. 60, p. 54-70 17 p.

    Research output: Contribution to journalArticlepeer-review

  4. Genomic investigation unmasks evidence of transmission across mycobacterium abscessus cystic fibrosis patients

    Alateah, S., Peters, C., Dhasmana, DJ., Pettigrew, K., Fallon, R., Seagar, A., Sloan, DJ., Laurenson, IF., Holden, M. & Gillespie, S., 15 Dec 2017, In: Thorax. 72, Suppl 3, p. A56-A56

    Research output: Contribution to journalAbstractpeer-review

  5. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study

    Walsh, S. L. F., Maher, T. M., Kolb, M., Poletti, V., Nusser, R., Richeldi, L., Vancheri, C., Wilsher, M. L., Antoniou, K. M., Behr, J., Bendstrup, E., Brown, K., Calandriello, L., Corte, T. J., Cottin, V., Crestani, B., Flaherty, K., Glaspole, I., Grutters, J., Inoue, Y. & 25 others, Kokosi, M., Kondoh, Y., Kouranos, V., Kreuter, M., Johannson, K., Judge, E., Ley, B., Margaritopoulos, G., Martinez, F. J., Molina-Molina, M., Morais, A., Nunes, H., Raghu, G., Ryerson, C. J., Selman, M., Spagnolo, P., Taniguchi, H., Tomassetti, S., Valeyre, D., Wijsenbeek, M., Wuyts, W., Hansell, D., Wells, A., IPF Project Consortium & Dhasmana, D. J., 31 Aug 2017, In: European Respiratory Journal. 50, 2, 10 p., 1700936.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging

    Sullivan, F. M., Mair, F. S., Anderson, W., Armory, P., Briggs, A., Chew, C., Dorward, A., Haughney, J., Hogarth, F., Kendrick, D., Littleford, R., Mcconnachie, A., McCowan, C., Mcmeekin, N., Patel, M., Rauchhaus, P., Ritchie, L., Robertson, C., Robertson, J., Robles-Zurita, J. & 8 others, Sarvesvaran, J., Sewell, H., Sproule, M., Taylor, T., Tello, A., Treweek, S., Vedhara, K. & Schembri, S., 1 Jan 2021, In: European Respiratory Journal. 57, 1, 11 p., 2000670.

    Research output: Contribution to journalArticlepeer-review

  2. Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg−1 rifampicin

    PanACEA Consortium, Te Brake, L. H. M., de Jager, V., Narunsky, K., Vanker, N., Svensson, E. M., Phillips, P. P. J., Gillespie, S. H., Heinrich, N., Hoelscher, M., Dawson, R., Diacon, A. H., Aarnoutse, R. E. & Boeree, M. J., 4 Feb 2021, In: European Respiratory Journal.

    Research output: Contribution to journalArticlepeer-review

  3. Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis

    Kodama, C., Lange, B., Olaru, I. D., Khan, P., Lipman, M., Seddon, J. A., Sloan, D., Grandjean, L., Abbas Ferrand, R. & Kranzer, K., 26 Oct 2017, In: European Respiratory Journal. 50, 4, 1701044.

    Research output: Contribution to journalReview articlepeer-review

  4. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study

    Walsh, S. L. F., Maher, T. M., Kolb, M., Poletti, V., Nusser, R., Richeldi, L., Vancheri, C., Wilsher, M. L., Antoniou, K. M., Behr, J., Bendstrup, E., Brown, K., Calandriello, L., Corte, T. J., Cottin, V., Crestani, B., Flaherty, K., Glaspole, I., Grutters, J., Inoue, Y. & 25 others, Kokosi, M., Kondoh, Y., Kouranos, V., Kreuter, M., Johannson, K., Judge, E., Ley, B., Margaritopoulos, G., Martinez, F. J., Molina-Molina, M., Morais, A., Nunes, H., Raghu, G., Ryerson, C. J., Selman, M., Spagnolo, P., Taniguchi, H., Tomassetti, S., Valeyre, D., Wijsenbeek, M., Wuyts, W., Hansell, D., Wells, A., IPF Project Consortium & Dhasmana, D. J., 31 Aug 2017, In: European Respiratory Journal. 50, 2, 10 p., 1700936.

    Research output: Contribution to journalArticlepeer-review

ID: 256048328

Top